Cansino Biologics Inc. Posted 170.2 Million Yuan Net Loss in First Quarter of 2023

Cansino Biologics Inc. (康希诺生物股份公司) (688185.SH) reported a net loss of 170.2 million yuan in the first quarter of 2023, reversing a net profit of 114.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 100.6 million yuan in revenue, down 79.9% year-on-year.

At the end of the reporting period, it had 11.2 billion yuan in total assets and 4.1 billion yuan in total liabilities, with a liability-to-asset ratio of 36.9%.